These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 21455621

  • 1. Immunogenic characterization of the chimeric surface antigen 1 and 2 (SAG1/2) of Toxoplasma gondii expressed in the yeast Pichia pastoris.
    Lau YL, Thiruvengadam G, Lee WW, Fong MY.
    Parasitol Res; 2011 Sep; 109(3):871-8. PubMed ID: 21455621
    [Abstract] [Full Text] [Related]

  • 2. Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses.
    Li WS, Chen QX, Ye JX, Xie ZX, Chen J, Zhang LF.
    Parasitol Res; 2011 Sep; 109(3):637-44. PubMed ID: 21404064
    [Abstract] [Full Text] [Related]

  • 3. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris.
    Lau YL, Fong MY.
    Exp Parasitol; 2008 Jul; 119(3):373-8. PubMed ID: 18457835
    [Abstract] [Full Text] [Related]

  • 4. Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles.
    Chuang SC, Ko JC, Chen CP, Du JT, Yang CD.
    Parasit Vectors; 2013 Feb 11; 6():34. PubMed ID: 23398973
    [Abstract] [Full Text] [Related]

  • 5. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
    Sánchez-López EF, Corigliano MG, Albarracín RM, Sander VA, Legarralde A, Bengoa-Luoni SA, Clemente M.
    Parasit Vectors; 2019 Mar 25; 12(1):140. PubMed ID: 30909938
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.
    Meng M, He S, Zhao G, Bai Y, Zhou H, Cong H, Lu G, Zhao Q, Zhu XQ.
    Parasit Vectors; 2012 Nov 26; 5():273. PubMed ID: 23181694
    [Abstract] [Full Text] [Related]

  • 7. Biological role of surface Toxoplasma gondii antigen in development of vaccine.
    Liu KY, Zhang DB, Wei QK, Li J, Li GP, Yu JZ.
    World J Gastroenterol; 2006 Apr 21; 12(15):2363-8. PubMed ID: 16688826
    [Abstract] [Full Text] [Related]

  • 8. Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris.
    Zhou H, Gu Q, Zhao Q, Zhang J, Cong H, Li Y, He S.
    Parasitol Res; 2007 Mar 21; 100(4):829-35. PubMed ID: 17058109
    [Abstract] [Full Text] [Related]

  • 9. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
    Fang R, Feng H, Nie H, Wang L, Tu P, Song Q, Zhou Y, Zhao J.
    Vaccine; 2010 Feb 17; 28(7):1803-7. PubMed ID: 20018269
    [Abstract] [Full Text] [Related]

  • 10. Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2.
    Yang CD, Chang GN, Chao D.
    Parasitol Res; 2004 Jan 17; 92(1):58-64. PubMed ID: 14605877
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii.
    Fang R, Feng H, Hu M, Khan MK, Wang L, Zhou Y, Zhao J.
    Vet Parasitol; 2012 Jun 08; 187(1-2):140-6. PubMed ID: 22336771
    [Abstract] [Full Text] [Related]

  • 12. Compound DNA vaccine encoding SAG1/ SAG3 with A2/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondii.
    Cong H, Zhang M, Xin Q, Wang Z, Li Y, Zhao Q, Zhou H, He S.
    Parasit Vectors; 2013 Mar 13; 6():63. PubMed ID: 23497561
    [Abstract] [Full Text] [Related]

  • 13. The conformation of purified Toxoplasma gondii SAG1 antigen, secreted from engineered Pichia pastoris, is adequate for serorecognition and cell proliferation.
    Biemans R, Grégoire D, Haumont M, Bosseloir A, Garcia L, Jacquet A, Dubeaux C, Bollen A.
    J Biotechnol; 1998 Dec 11; 66(2-3):137-46. PubMed ID: 9866865
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Grzybowski M, Dlugonska H.
    Vaccine; 2011 Jan 17; 29(4):821-30. PubMed ID: 21087690
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
    Qu D, Wang S, Cai W, Du A.
    Vaccine; 2008 Aug 18; 26(35):4541-8. PubMed ID: 18590785
    [Abstract] [Full Text] [Related]

  • 16. Construction of Toxoplasma gondii SRS29C nucleic acid vaccine and comparative immunoprotective study of an SRS29C and SAG1 combination.
    Yan A, Tian J, Ye J, Gao C, Ye L, Zhang D, Song Q.
    Mol Biochem Parasitol; 2024 Sep 18; 259():111630. PubMed ID: 38795969
    [Abstract] [Full Text] [Related]

  • 17. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B, Lu S, Tong Q, Kong Q, Lou D.
    Vaccine; 2013 Sep 23; 31(41):4578-84. PubMed ID: 23928460
    [Abstract] [Full Text] [Related]

  • 18. [Immune response elicited by the recombinant protein and plasmid DNA of complex antigen ROP2-SAG1 from Toxoplasma gondii].
    Li WS, Xie ZX, Chen QX, Chen S, Zhang LF.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Oct 30; 28(5):359-63. PubMed ID: 21351549
    [Abstract] [Full Text] [Related]

  • 19. The Development of Toxoplasma gondii Recombinant Trivalent Chimeric Proteins as an Alternative to Toxoplasma Lysate Antigen (TLA) in Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection of Immunoglobulin G (IgG) in Small Ruminants.
    Ferra BT, Chyb M, Sołowińska K, Holec-Gąsior L, Skwarecka M, Baranowicz K, Gatkowska J.
    Int J Mol Sci; 2024 Apr 16; 25(8):. PubMed ID: 38673969
    [Abstract] [Full Text] [Related]

  • 20. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
    Dziadek B, Gatkowska J, Grzybowski M, Dziadek J, Dzitko K, Dlugonska H.
    Exp Parasitol; 2012 May 16; 131(1):133-8. PubMed ID: 22445587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.